179 related articles for article (PubMed ID: 37199721)
1. Patient-Specific Targeting of the T-Cell Receptor Variable Region as a Therapeutic Strategy in Clonal T-Cell Diseases.
Lucero OM; Lee JA; Bowman J; Johnson K; Sapparapu G; Thomas JK; Fan G; Chang BH; Thiel-Klare K; Eide CA; Okada C; Palazzolo M; Lind E; Kosaka Y; Druker BJ; Lydon N; Bowers PM
Clin Cancer Res; 2023 Oct; 29(20):4230-4241. PubMed ID: 37199721
[TBL] [Abstract][Full Text] [Related]
2. T cell receptor Vbeta repertoire usage and clonal expansion of T cells in chronic myelogenous leukemia.
Li YQ; Yang LJ; Chen SH; Zhang YP; Zhang XL; Luo GX
Chin Med J (Engl); 2004 Jun; 117(6):840-3. PubMed ID: 15198883
[TBL] [Abstract][Full Text] [Related]
3. Generation of diffuse large B cell lymphoma-associated antigen-specific Vα6/Vβ13+T cells by TCR gene transfer.
Yin Q; Zha X; Yang L; Chen S; Zhou Y; Wu X; Li Y
J Hematol Oncol; 2011 Jan; 4():2. PubMed ID: 21223579
[TBL] [Abstract][Full Text] [Related]
4. Selective T cell receptor Vbeta gene usage by alloreactive T cells responding to defined HLA-DR alleles.
Lobashevsky A; Kotb M; Gaber AO
Transplantation; 1996 Nov; 62(9):1332-40. PubMed ID: 8932281
[TBL] [Abstract][Full Text] [Related]
5. Generation and optimization of off-the-shelf immunotherapeutics targeting TCR-Vβ2+ T cell malignancy.
Ren J; Liao X; Lewis JM; Chang J; Qu R; Carlson KR; Foss F; Girardi M
Nat Commun; 2024 Jan; 15(1):519. PubMed ID: 38225288
[TBL] [Abstract][Full Text] [Related]
6. Monoclonal TCR-Vbeta13.1+/CD4+/NKa+/CD8-/+dim T-LGL lymphocytosis: evidence for an antigen-driven chronic T-cell stimulation origin.
Garrido P; Ruiz-Cabello F; Bárcena P; Sandberg Y; Cantón J; Lima M; Balanzategui A; González M; López-Nevot MA; Langerak AW; García-Montero AC; Almeida J; Orfao A
Blood; 2007 Jun; 109(11):4890-8. PubMed ID: 17303697
[TBL] [Abstract][Full Text] [Related]
7. Case Report: An unclassified T cell lymphoma subtype with co-expression of TCR αβ and γ chains revealed by single cell sequencing.
Song W; Wang G; Wang C; Liu L; Zhang L; Zhang R; Zhang H; Shi K
Front Immunol; 2023; 14():1184383. PubMed ID: 37325644
[TBL] [Abstract][Full Text] [Related]
8. Unraveling graft-versus-host disease and graft-versus-leukemia responses using TCR Vβ spectratype analysis in a murine bone marrow transplantation model.
Fanning SL; Zilberberg J; Stein J; Vazzana K; Berger SA; Korngold R; Friedman TM
J Immunol; 2013 Jan; 190(1):447-57. PubMed ID: 23203931
[TBL] [Abstract][Full Text] [Related]
9. Failure of anti-T-cell receptor V beta antibodies to consistently identify a malignant T-cell clone in Sézary syndrome.
Bigler RD; Boselli CM; Foley B; Vonderheid EC
Am J Pathol; 1996 Nov; 149(5):1477-83. PubMed ID: 8909237
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-2-activated murine cell lines with macrophage- and B-lymphoblast-lytic activity.
Suzuki H; Ikemoto M; Yokoyama A; Kamitani T; Yamashita N; Maruyama M; Yano S
Cell Immunol; 1991 Jan; 132(1):127-39. PubMed ID: 1829651
[TBL] [Abstract][Full Text] [Related]
11. [Analysis of selected usage and clonal expansion of TCR Vbeta repertoire of peripheral blood T cells in patients with non-Hodgkin's lymphoma].
Lu YH; Li YQ; Yang LJ; Chen SH; Zhang T; Luo GX; Zhang YP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2002 Apr; 10(2):119-21. PubMed ID: 12513812
[TBL] [Abstract][Full Text] [Related]
12. Germline transcription of multiple TCR-Vbeta genes in cloned T-cell lines.
Abbey JL; O'Neill HC
Immunol Cell Biol; 2004 Aug; 82(4):393-9. PubMed ID: 15283849
[TBL] [Abstract][Full Text] [Related]
13. Single TCR-Vβ2 evaluation discloses the circulating T cell clone in Sezary syndrome: one family fits all!
Scala E; Abeni D; Pomponi D; Russo N; Russo G; Narducci MG
Arch Dermatol Res; 2015 Aug; 307(6):487-93. PubMed ID: 25733488
[TBL] [Abstract][Full Text] [Related]
14. Monitoring malignant T-cell clones by direct TCR expression assay in patients with leukemic cutaneous T-cell lymphoma during extracorporeal photopheresis.
Ni X; Maiti S; Redko A; Bijani P; Duvic M
Photodermatol Photoimmunol Photomed; 2022 Mar; 38(2):158-168. PubMed ID: 34543492
[TBL] [Abstract][Full Text] [Related]
15. Presence of oligoclonal T cells in cerebrospinal fluid of a child with multiphasic disseminated encephalomyelitis following hepatitis A virus infection.
Oleszak EL; Lin WL; Legido A; Melvin J; Hardison H; Hoffman BE; Katsetos CD; Platsoucas CD
Clin Diagn Lab Immunol; 2001 Sep; 8(5):984-92. PubMed ID: 11527815
[TBL] [Abstract][Full Text] [Related]
16. Changes in the peripheral blood T-Cell receptor V beta repertoire in vivo and in vitro during shigellosis.
Islam D; Wretlind B; Lindberg AA; Christensson B
Infect Immun; 1996 Apr; 64(4):1391-9. PubMed ID: 8606106
[TBL] [Abstract][Full Text] [Related]
17. [Viral superantigens].
Us D
Mikrobiyol Bul; 2016 Jul; 50(3):491-504. PubMed ID: 27525406
[TBL] [Abstract][Full Text] [Related]
18. T cell receptor engineering of primary NK cells to therapeutically target tumors and tumor immune evasion.
Morton LT; Wachsmann TLA; Meeuwsen MH; Wouters AK; Remst DFG; van Loenen MM; Falkenburg JHF; Heemskerk MHM
J Immunother Cancer; 2022 Mar; 10(3):. PubMed ID: 35288464
[TBL] [Abstract][Full Text] [Related]
19. A Novel Approach for the Treatment of T Cell Malignancies: Targeting T Cell Receptor Vβ Families.
Wang J; Urbanska K; Sharma P; Nejati R; Shaw L; Lim MS; Schuster SJ; Jr DJP
Vaccines (Basel); 2020 Oct; 8(4):. PubMed ID: 33142718
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of TCR Vbeta subfamily T cell expansion in NOD/SCID mice transplanted with human cord blood hematopoietic stem cells.
Lin C; Chen S; Yang L; Tan Y; Bai X; Li Y
Hematology; 2007 Aug; 12(4):325-30. PubMed ID: 17654060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
